New Orders
GenIP Plc has announced several new orders, including a 12-month framework agreement with a leading Hong Kong research university valued at approximately $20,000 annually, and a first-time engagement with a London-based university. The company also secured its first Canadian client, a major research university, and an engagement with a North American public research university. Additionally, a South African client has deployed GenIP's Invention Validator product, valued at approximately $14,500 for a single evaluation, which operates with a 60% margin floor. GenIP anticipates announcing its FY2025 results and outlook within two weeks.
Select text to share a quote on X · sign in to keep highlights & notes in your TEK notes
GenIP Plc (AIM: GNIP), a technology consultancy providing AI-driven services to help research organisations and corporations commercialise their innovations, is pleased to announce the following new orders.
#1 Ranked Research University in Hong Kong
The Company has entered into a 12-month framework agreement with a leading Hong Kong research university, with an option to renew for a further 12 months. The agreement enables portfolio-level evaluations of up to 10 technologies per order, with orders placed by the university as required. The engagement is valued at approximately $20,000 per year, with potential for additional work beyond the initial scope.
Major UK Higher Education Institution
The Company has secured a first-time engagement with a well-established modern university in London, recognised for its strengths in applied research, engineering, and technology. The initial order covers 10 reports, with the likelihood of additional repeat orders to evaluate the institution's broad innovation portfolio.
South African Client: Invention Validator
A South African client has deployed the Company's recently launched Invention Validator product, representing one of the first engagements for this offering. The engagement is valued at approximately $14,500 for a single technology evaluation. The product is currently operating with a 60% margin floor, supporting strong unit economics as adoption scales.
Canadian and US Research Universities
The Company has secured its first Canadian client, one of Canada's leading research universities, with over 65,000 students and a strong international reputation in AI, engineering, health sciences, and technology research. The Company has also secured an engagement with one of North America's leading public research universities, internationally recognised for its programmes in engineering, AI, computer science, and technology innovation. Comparable institutions place orders monthly, and we are confident we'll maintain a similar relationship with our new clients.
The Company will announce their FY2025 results within the next two weeks and will include an outlook at that time.
Melissa Cruz, CEO of GenIP, commented:
"Securing a framework agreement with the #1 ranked university for patent influence in China is a major validation of our new AI-driven products.
More broadly, we are delighted with the response to our expanding range of products and believe GenIP is perfectly positioned for another year of top-line growth in 2026 as the number of long-term repeat customers grows."
Service Offerings
GenIP operates through two synergistic service lines:
| Service | Description | Value Proposition |
| IP Commercialization Services | End-to-end engagement to help research organisations commercialise innovations | Provides cost-effective, broad support to achieve our clients' strategic objectives |
Together, these services form a unified GenAI-enabled platform for innovation triage and execution.
Vision & Strategy
- Organic Expansion
- Service Deepening
- Strategic Acquisitions
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.